Cleared Special

K130656 - IFUSION

K130656 is an FDA 510(k) clearance for IFUSION, manufactured by Optovue, Inc.. The device is a Class 2 Ophthalmic device with product code HKI cleared through the Special 510(k) pathway after a 113-day FDA review.

K130656 · Optovue, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2013
Decision
113d
Days
Class 2
Risk

K130656 is an FDA 510(k) clearance for the IFUSION. Classified as Camera, Ophthalmic, Ac-powered (product code HKI), Class II - Special Controls.

Submitted by Optovue, Inc. (Fremont, US). The FDA issued a Cleared decision on July 3, 2013 after a review of 113 days - within the typical 510(k) review window.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.1120 - the FDA ophthalmic device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Optovue, Inc. devices

FDA 510(k) Submission Details - K130656

510(k) Number K130656 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 12, 2013
Decision Date July 03, 2013
Days to Decision 113 days
Submission Type Special
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
3d slower than avg
Panel avg: 110d · This submission: 113d
Pathway characteristics
Modification to existing cleared device.

HKI Device Classification - Class 2, Special Controls

Product Code HKI Camera, Ophthalmic, Ac-powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.1120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HKI Camera, Ophthalmic, Ac-powered

All 60
Devices cleared under the same product code (HKI) and FDA review panel - the closest regulatory comparables to K130656.
RetiCapture
K173474 · Ilooda Co,., Ltd. · Jul 2018
Nexy
K180306 · Next Sight Srl · Jun 2018
Optomed Aurora Camera with Aurora Retinal Module and Aurora Anterior Module
K180378 · Optomed OY · Apr 2018
PANOPTIC
K121405 · Welch Allyn, Inc. · Dec 2012
DIGITAL RETINAL CAMERA
K111612 · Canon, Inc. · Sep 2011
DIGITAL RETINAL CAMERA, CR-1 MARK II
K090466 · Canon, Inc. · Mar 2009